Annual Total Liabilities
$124.50 M
+$53.53 M+75.42%
December 31, 2023
Summary
- As of February 12, 2025, GLUE annual total liabilities is $124.50 million, with the most recent change of +$53.53 million (+75.42%) on December 31, 2023.
- During the last 3 years, GLUE annual total liabilities has risen by +$26.40 million (+26.91%).
- GLUE annual total liabilities is now at all-time high.
Performance
GLUE Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$109.62 M
-$9.82 M-8.22%
September 30, 2024
Summary
- As of February 12, 2025, GLUE quarterly total liabilities is $109.62 million, with the most recent change of -$9.82 million (-8.22%) on September 30, 2024.
- Over the past year, GLUE quarterly total liabilities has dropped by -$4.60 million (-4.03%).
- GLUE quarterly total liabilities is now -54.55% below its all-time high of $241.22 million, reached on March 31, 2021.
Performance
GLUE Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
GLUE Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +75.4% | -4.0% |
| 3 y3 years | +26.9% | +54.5% |
| 5 y5 years | +435.7% | +54.5% |
GLUE Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +561.8% | -11.9% | +482.7% |
| 5 y | 5-year | at high | +561.8% | -54.5% | +793.9% |
| alltime | all time | at high | +561.8% | -54.5% | +793.9% |
Monte Rosa Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $109.62 M(-8.2%) |
| Jun 2024 | - | $119.44 M(+4.6%) |
| Mar 2024 | - | $114.23 M(-8.3%) |
| Dec 2023 | $124.50 M(+75.4%) | $124.50 M(+84.2%) |
| Sep 2023 | - | $67.58 M(+4.0%) |
| Jun 2023 | - | $64.96 M(-0.5%) |
| Mar 2023 | - | $65.30 M(-8.0%) |
| Dec 2022 | $70.98 M | $70.98 M(+6.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $66.51 M(+5.6%) |
| Jun 2022 | - | $63.01 M(+213.0%) |
| Mar 2022 | - | $20.13 M(+7.0%) |
| Dec 2021 | $18.81 M(-80.8%) | $18.81 M(+27.6%) |
| Sep 2021 | - | $14.74 M(+20.2%) |
| Jun 2021 | - | $12.26 M(-94.9%) |
| Mar 2021 | - | $241.22 M(+145.9%) |
| Dec 2020 | $98.11 M(+322.1%) | $98.11 M |
| Dec 2019 | $23.24 M | - |
FAQ
- What is Monte Rosa Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics annual total liabilities year-on-year change?
- What is Monte Rosa Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics quarterly total liabilities year-on-year change?
What is Monte Rosa Therapeutics annual total liabilities?
The current annual total liabilities of GLUE is $124.50 M
What is the all time high annual total liabilities for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high annual total liabilities is $124.50 M
What is Monte Rosa Therapeutics annual total liabilities year-on-year change?
Over the past year, GLUE annual total liabilities has changed by +$53.53 M (+75.42%)
What is Monte Rosa Therapeutics quarterly total liabilities?
The current quarterly total liabilities of GLUE is $109.62 M
What is the all time high quarterly total liabilities for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high quarterly total liabilities is $241.22 M
What is Monte Rosa Therapeutics quarterly total liabilities year-on-year change?
Over the past year, GLUE quarterly total liabilities has changed by -$4.60 M (-4.03%)